NitroMed CEO, CFO resign, board appoints new senior management

By Elaine Rigoli

Tampa, Fla., March 21 - NitroMed, Inc. announced on Tuesday that Michael Loberg resigned from his position as the company's president, chief executive officer and director, and Lawrence Bloch resigned from his position as the company's chief financial officer and chief business officer.

Argeris (Jerry) Karabelas has been appointed interim CEO, in addition to his role as chairman of the company, according to a company news release.

Kenneth Bate has been appointed chief operating officer and CFO, the release said.

NitroMed, located in Lexington, Mass., is a research-based emerging pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.